Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hyperfine, Inc.
Report date December 29, 2021 · Filed December 20, 2022
Jointly reported with HealthCor Group, LLC, Cohen Arthur Bruce, Healey Joseph Patrick
Section 16 reporting ended · disclosed 2022-12-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 1,100,000 |
Reported balance
After 2021-12-29 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-12-29 · Purchase · Acquired 100,000 · Balance 1,100,000 F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. F2: Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,250,000 |
Last balance in matching sequence
After 2022-02-03 transaction · row 8
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 3 · 2022-01-10 · Purchase · Acquired 13,677 · Balance 1,113,677 F3: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4. F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Row 4 · 2022-01-11 · Purchase · Acquired 2,913 · Balance 1,116,590 F4: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive. F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Row 5 · 2022-01-12 · Purchase · Acquired 8,410 · Balance 1,125,000 F5: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive. F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Row 6 · 2022-01-21 · Purchase · Acquired 25,000 · Balance 1,150,000 F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Row 7 · 2022-01-26 · Purchase · Acquired 78,053 · Balance 1,228,053 F6: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive. F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Row 8 · 2022-02-03 · Purchase · Acquired 21,947 · Balance 1,250,000 F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-12-16 transaction · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · 2022-12-16 · Other · Disposed 5,534,000 · Balance 0 F7: Sponsor distributed these shares to its members on a pro rata basis for no consideration. F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. F8: A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly. |
| Class A Common StockSEC Table I · non-derivative | Direct | 5,534,000 |
Reported balance
Holding disclosure · report date 2021-12-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,534,000 F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.
F2: Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities.
F3: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4.
F4: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive.
F5: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive.
F6: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive.
F7: Sponsor distributed these shares to its members on a pro rata basis for no consideration.
F8: A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | OtherClass A Common Stock | 5,534,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 9 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F7 · kind: Sponsor distributed these shares to its members on a pro rata basis for no consideration. F1 · ownership.direct: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. F8 · ownership.direct: A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly. Read SEC document |
| February 03, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 21,947 | $4.00 | $87,788.00 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 8 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,250,000 F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Read SEC document |
| January 26, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 78,053 | $3.75 | $292,464.59 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 7 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,228,053 F6 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive. F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Read SEC document |
| January 21, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 25,000 | $4.50 | $112,550.00 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 6 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,150,000 F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Read SEC document |
| January 12, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 8,410 | $6.57 | $55,245.29 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 5 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,125,000 F5 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive. F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Read SEC document |
| January 11, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 2,913 | $6.73 | $19,598.66 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 4 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,116,590 F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive. F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Read SEC document |
| January 10, 2022 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 13,677 | $6.70 | $91,608.55 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 3 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,113,677 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4. F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. Read SEC document |
| December 29, 2021 Filed Dec 20, 2022 16:58 UTC | Hyperfine, Inc. HYPR · Entity 6865 | PurchaseClass A Common Stock | 100,000 | $7.00 | $700,000.00 |
DisclosureSEC source: 0001062993-22-024233 · form4.xml · nonDerivative · entry 2 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,100,000 F1 · ownership.nature: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein. F2 · ownership.nature: Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:10 UTC | Hyperfine, Inc. HYPR · Entity 6865 | ConversionClass B ordinary shares · Derivative | 4,920,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-153687 · tm2136411-1_4seq1.xml · derivative · entry 4 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Shares · 4,920,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · kind: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · price: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · derivative.exercise_date: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · derivative.expiration_date: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.direct: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by HealthCor Group and Messrs. Cohen and Healey. Each such reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:10 UTC | Hyperfine, Inc. HYPR · Entity 6865 | ConversionClass A ordinary shares · Derivative | 614,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-153687 · tm2136411-1_4seq1.xml · derivative · entry 3 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Shares · 614,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · kind: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · price: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · derivative.exercise_date: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · derivative.expiration_date: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.direct: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by HealthCor Group and Messrs. Cohen and Healey. Each such reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:10 UTC | Hyperfine, Inc. HYPR · Entity 6865 | GrantClass A Common Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-153687 · tm2136411-1_4seq1.xml · nonDerivative · entry 2 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,534,000 F3 · shares: The Reporting Persons have voting and dispositive power over the reported securities, which were acquired by affiliates of the Reporting Persons pursuant to a PIPE Investment in connection with the completion of the Business Combination. F1 · price: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.direct: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by HealthCor Group and Messrs. Cohen and Healey. Each such reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:10 UTC | Hyperfine, Inc. HYPR · Entity 6865 | ConversionClass A common stock | 5,534,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-153687 · tm2136411-1_4seq1.xml · nonDerivative · entry 1 HC Sponsor LLC · CIK 0001833772 · 10% owner HealthCor Group, LLC · CIK 0001409307 · 10% owner Cohen Arthur Bruce · CIK 0001343780 · 10% owner Healey Joseph Patrick · CIK 0001343779 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,534,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F1 · price: In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Hyperfine, Inc., Liminal Sciences, Inc. and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), HealthCor domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hyperfine, Inc." ("Hyperfine"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of HealthCor, which were previously convertible into Class A ordinary shares of HealthCor, were automatically converted into shares of Class A common stock of Hyperfine, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.direct: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by HealthCor Group and Messrs. Cohen and Healey. Each such reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.